Table 2.
NR3C1 methylation prevalence and group cutoffs
| CpG site | Number (%) of saliva samples with methylation > 0% for each CpG | Median methylation level (% DNA being methylated) among the samples with methylation > 0%a | ||
|---|---|---|---|---|
| Males N = 524 |
Females N = 625 |
Males | Females | |
| CpG1 | 87 (16.6) | 118 (18.9) | 3.1 | 3.9 |
| CpG2 | 64 (12.2) | 79 (12.6) | 3.4 | 3.7 |
| CpG3 | 261 (49.8) | 319 (51.0) | 3.6 | 3.4 |
| CpG4 | 107 (20.4) | 109 (17.4) | 3.2 | 3.7 |
| CpG5 | 40 (7.6) | 56 (9.0) | 4.3 | 4.8 |
The Kupol Study, Stockholm 2013–2015
aMedians used for categorizing an individual into low methylation group or high methylation group